Viewpoints

Spinning Success? The Benefits of University Spinouts

December 02, 2021

Pharma and biotech are ruling the roost in terms of university innovation, but European spinouts are still experiencing barriers to long-term success.

Making a Difference in European Bio/Pharma

November 02, 2021

Manufacturing capacity expansion is high on the agenda for many bio/pharma companies and service providers in Europe.

New Beginnings

October 02, 2021

Change of roster does not change the goal line. We are all patients first.

The Next Chapter

September 02, 2021

While the players may change, pharma’s patients-first focus should not.

Drug Pricing Scrutiny Increases in Europe

August 02, 2021

Excessive drug pricing is being scrutinized across Europe, as hefty fines are set to send out a clear message of intolerance to anti-competition conduct.

Tackling Counterfeit Medicines

June 28, 2021

Pharmaceutical Technology discussed the potential increased risk of counterfeit medicines in the UK post-Brexit and how blockchain could be a useful tool to tackle the issue.

Viewpoint: Data Integrity and Its Ties with Personal Integrity

June 21, 2021

The root cause of the most serious integrity issues has generally been a lapse of ethical behavior on the part of an individual.

Divest and Conquer? GSK's Future is in Question

June 02, 2021

GSK’s position is raising concerns as it continues working towards its separation of businesses.

A “We are the World” Vaccination Effort?

June 02, 2021

Bio/pharmaceutical manufacturers have made a good first step toward global vaccination through pledging doses at no- to low-profit rates.

From the Chairman: Technology Advances Foster New Therapies

June 02, 2021

Technology advances foster new therapies.